Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.61K | Sales 2023 | 555 366.74 | Capitalization | 39.72M 26.24M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.86M | Net income 2023 | -20M -13.22M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.86M | Net cash position 2023 | 3.44M 2.28M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |